INFORMED BATTLE OCCUPATIONAL AND ENVIRONMENTAL ISSUES

2006-12-27T20:25:00.000-08:00

Anthroposophical Medicine

Directory of Anthroposophical Physicians
University of Michigan: Integrative Medicine
Rudolf Steiner Health Center

Anthroposophical medicine is a holistic and salutogenetic approach to health. It thus focuses on ensuring that the conditions for health are present in a person; combating illness is often necessary but is insufficient alone. The approach was founded in the 1920s by Rudolf Steiner in conjunction with Ita Wegman.

This approach to medicine begins from the proposition that true healing takes place when the body is stimulated to overcome the influences that are causing illness, whether these arise from its own constitution or the surroundings — whether they be poisonous substances, antagonistic organisms (bacterial or viral), or psychological states. Under circumstances where it is not possible to support the body's own resistance, it may be necessary to overcome symptoms by purely external means such as surgery and allopathic medicine offer. As conventional medicines and therapies may also be employed, anthroposophical medicine provides an extension of conventional medical approaches rather than an alternative to these.

As a variety of influences may be causing illness, a corresponding range of treatment possibilities are employed. Therapeutic approaches presently used by anthroposophical doctors include anthroposophic remedies based upon homeopathic principles, oil dispersion baths, massage therapy, artistic therapies to heal the psychological causes of illness, and biographical therapy to establish or re-establish a sense of purpose in the ill person. There are specialized trainings in each of these therapeutic professions, as well as in anthroposophical nursing and medicine. An anthroposophic doctor must also have a medical degree from an established and certified medical school. ( All text is available under the terms of the GNU Free Documentation License)

2006-12-27T18:13:00.000-08:00

Page Undergoing Update
Dec. 27th, 2006

2006-12-27T17:47:00.000-08:00

Polarity Therapy

Polarity Therapy is an alternative health care system developed by American doctor Randolph Stone DO, DC, ND (1890-1981). It is a synthesis of ancient Eastern and modern Western health care ideas centered on the concept of a Human Energy Field.^[1] Polarity Therapy concepts and methods were developed by Stone over the course of more than fifty years of medical practice and research including extensive worldwide travel. Using touch, verbal interaction, exercise, nutrition and other methods,^[2] Polarity Therapy seeks to balance and restore the natural flow of subtle energy, resulting in improved health and fitness on all levels.

Between 1947 and 1954, Stone published seven books describing Polarity Therapy principles and applications. These were subsequently consolidated into three volumes: Polarity Therapy Vol. I and Vol. II (CRCS, 1986), and Health-Building (The Book Publishing Co., 1999).

Principles of Polarity Therapy:^[3]

-Energy precedes form. A subtle, largely invisible energetic system is considered to be the substrate for all phenomena, comparable to the electromagnetic bond between electron and proton that forms atoms. If the energetic flow is corrected and restored to its original design, the form will follow. Blockages in the flow of energy lead to pain and disease. While an electromagnetic metaphor is often used, Stone emphasized that the energy concept had a larger context; he referred to it as the "Breath of Life"^[4] and used esoteric language (such as ki, chi, prana and life force) from spiritual traditions (especially mystic Christianity^[5], Ayurveda,^[6] Taoism, Hinduism^[7], Buddhism,^[8] Sufism and Yoga^[9] to describe its deep identity and implications.

-Physical body, emotions, mind and spirit are considered to be layers of a unified interactive system; events on one layer affect the other layers. The physical body is described as continually precipitating from the subtle layers, as spiritual factors and mental attitudes coalesce into form. The physical body in turn sends a return information signal back to the subtle layers, thus creating a recurrent feedback loop.^[10]

-Reciprocal complementary (polarized, hence the name of the therapy) forces, known as Yin and Yang in the Orient, are universal ordering principles. These dualistic forces have been described in many ways: attraction-repulsion, expansion-contraction, masculine-feminine, hyper-hypo, spirit-matter, invisible-visible, as well as in numerous other contexts. These dualities are said to be mediated by a subtle third neutral factor, leading to the idea that phenomena are essentially triune in nature. In Ayurveda, the three factors are known as Rajas, Tamas, and Satva.

-The yogic concept of the chakra, a series of functional energetic transformers located along the spine, is embraced and applied in numerous ways. The five chakras governing physical and emotional function are earth (pelvic floor- structure and security), water (pelvis- circulation and connection), fire (solar plexus- digestion, movement and will power), air (chest- respiration and desire), and ether (throat- expression, emotions and discrimination). Sixth and seventh chakras in the brow and crown are considered to be extra-physical in form and function.

-Polarity theory embraces the Ayurvedic concepts of reincarnation, karma and related esoteric spiritual ideas. According to Stone, the purpose of life is "the fulfillment of consciousness;"^[11] the enduring soul takes on a body to acquire experience for the purpose of self-understanding and God realization. Polarity therapy is exceptional in having an ever-present interest in the link between spirit-matter and mind-body, and exploring how these large contexts might apply to specific health conditions.

-Energetic forces and factors can be palpated by the sensitive listener, and they can be affected by touch, attitude, diet, movement, sound and numerous other methods.

-Polarity Therapy has been linked to many other health care modalities, and is considered an open, inclusive, still-evolving system that is informed by many disciplines and applicable in a wide range of contexts. In particular, Polarity therapy has a mutually-supportive relationship with Oriental medicine, Ayurveda, Craniosacral therapy and Osteopathy, which all explore the subtle energetic factors in health conditions from their particular cultural viewpoints.

-Polarity Therapy is exceptional in embracing quantum physics concepts earlier and more richly than other alternative health care systems.^[12]

-Substantial modern research supports the existence of an energy field and the plausibility of Polarity Therapy theory.^[13] In addition there are about ten titles on Polarity therapy, written by authors after Randolph Stone and covering many aspects of the method.^[14]

-Research supporting the validity of Polarity Therapy practice is not extensive or well-developed^[15] however anecdotal reports and nascent research continues to fuel growth in interest.^[16]

Polarity Therapy has four distinct areas of technique: touch, exercise, diet, and mental-emotional process. Polarity practitioners registered with the American Polarity Therapy Association should be knowledgeable in all four areas. However, most practitioners tend to favor one area over others, so the work may vary considerably from one practitioner to another.

As with all forms of body work, practitioners cannot and should not make any claims as to polarity's ability to heal a condition or illness. A person seeking alternative wellness techniques should closely monitor reactions to any technique. Additionally, since every practitioner is different, patients should work with more than one practitioner until they find someone that they consider a good match.

^ Oschman, J.: Energy Medicine, The Scientific Basis, page 10. (Churchill Livingstone, 2000). "In a few decades scientists have gone from a conviction that there is no such thing as an energy field around the human body, to an absolute certainty that it exists. Moreover, science is explaining the roles of energy fields in health and disease. The main reason for the recent change in outlook is the development of sensitive instruments that can detect the minute energy fields around the human body."
^ American Polarity Therapy Association: Standards for Practice (Fourth Edition), page 2. APTA, 2003.
^ Stone, R.: "Polarity Therapy, Vol. II", page 227 ff. CRCS, 1986.
^ Stone, R.: "Polarity Therapy Vol. I", page 2. CRCS, 1986.
^ Stone, R.: "The Mystic Bible." RSSB, 1956. Initially trained to be a Lutheran priest, Stone has dozens of Biblical references scattered throughout all his books.
^ Morningstar, A,: The Ayurvedic Guide to Polarity Therapy. Lotus Press, 2002. This presents Polarity concepts from the perspective of the Ayurvedic health care system
^ Burger, B.: Esoteric Anatomy. North Atlantic Books, 1998. This presents Polarity concepts including interpretations from a Hindu mythology perspective.
^ Sills, F.: The Polarity Process. North Atlantic, 2002. This gives presents Polarity concepts including interpretations from a Buddhist perspective.
^ Wehrli, K.: The Why in the Road. Earthlit Press, 2005. This gives an esoteric cosmology integrating Polarity concepts with Yogic mysticism.
^ Schwartz, G. & Russek, L.: "The Living Energy Universe," pages 274, 104. Hampton Roads, 1999.
^ Chitty, J. and Muller, M.L.: Energy Exercises, page 123-124. Polarity Press, 1990.
^ For example, these sentences written in 1948: "Research in atomic energy and the corresponding new viewpoint on matter prompts a re-orientation of the healing arts, in conformity with these modern discoveries. In this Wireless Energy Field [concept], ancient and modern science can meet... The Energy Principle is atomic in its concept and is a science of the future." -Stone, Polarity Therapy, Vol. I, pages 2,3. CRCS, 1986.
^ A currently leading resource summarizing the science is the work of James Oschman, PhD: Energy Medicine: The Scientific Basis (Churchill Livingstone, 2000) and Energy Medicine in Therapeutics and Human Performance (Butterworth-Heinemann, 2003).
^ For lists, see www.polaritytherapy.org/ or numerous other internet sites associated with individual Polarity therapy schools.
^ For example, see www.medicalcenter.osu.edu/patientcare/hospitalsandservices/programs/services/?ID=1489
^ For example, see www.stronghealth.com/news/article.cfm?art_ID=358&serviceline=11.

[edit] See also

Quantum-Touch

[edit] External links

Permission is granted to copy, distribute and/or modify this document

under the terms of the GNU Free Documentation License, Version 1.2

or any later version published by the Free Software Foundation;

with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts.

A copy of the license is included in the section entitled "GNU

Free Documentation License".

2006-11-24T17:57:00.000-08:00

RESOURCES

Anthroposophical Medicine

Polarity Therapy

2006-11-24T08:00:00.001-08:00

Page Undergoing Updating & Construction
November 24, 2006
Please Visit Us Again

ARTICLES

2006-11-24T07:49:00.000-08:00

Chronic Fatigue Syndrome
Exhibits overlapping symptoms to Multiple Chemical Sensitivities
CFC - Some Facts - Wikipedia

Ground Breaking Medical - Biochemical Paradigm of Chronic Disease

2006-11-20T19:28:00.000-08:00

"The physician should look for the force and nature of illness at its source. He is not to look at that which can be seen, for we are not called upon to extinguish the smoke but the fire itself."
Theophrastus Paracelsus

The NO/ONOO- Cycle Mechanism : Context & Indications for Treatment
by Martin Pall Ph.D

Source
CFSFM Research chat group
Yahoogroups.com
March 27th, 2006)

"This is going to be a long post. It contains the most important information on the cause of [chronic fatigue syndrome] CFS, [fibromyalgia] FM, [multiple chemical sensaitivity] MCS and related illnesses and how to effectively treat them.

I have been working to the cause of these illnesses for almost 8 years and will have a book coming out on this and many related topics from Haworth Medical Press that will provide much more information than is in this post. Cases of each of these illnesses are initiated by short term stressors, but instead of recovering after exposure, people become ill with one or more these chronic illnesses. The stressors implicated include viral, bacterial and in a few cases, protozoan infections, physical trauma (most commonly to the head and neck but also including physical trauma to other regions of the body), chemical exposure to such chemicals a volatile organic solvents or such pesticides as organophosphorus/carbamates, organochlorine pesticides or pyrethroid pesticides, carbon monoxide
exposure, severe psychological stress, certain mold toxins or ciguatoxin exposure. Each of these diverse stressors can initiate a process leading to increased nitric oxide levels. In some cases (infection) the iNOS form of nitric oxide synthase is involved but in most others, excessive NMDA activity is involved leading to increased nNOS activity. It follows that no single form of nitric oxide synthase is involved, but rather the common factor is nitric oxide. I have argued that the most important consequences of this are mediated not through nitric oxide itself but rather through the action of the oxidant product of nitric oxide, peroxynitrite.

Peroxynitrite synthesis

NO. + OO.- -------> ONOO-
(nitric (superoxide) (peroxynitrite)
oxide)

How does this initiate these chronic illnesses? They act by initiating a biochemical vicious cycle which is responsible for these chronic illnesses: The arrows represent 22 distinct biochemical mechanisms whereby one of the parameters listed stimulate the next parameter connected by an arrow. Of these 19 are very well documented in the biochemical literature and the remaining three appear to be correct but are less well documented. This vicious cycle, which we are now calling the NO/ONOO- cycle (based on the structures of nitric oxide and peroxynitrite (but pronounced, no, oh no!) is responsible for the chronic nature of these illnesses.

The NO/ONOO- cycle is based on five distinct principles, two of which I have already described. These principles are as follows:

The NO/ONOO- cycle mechanism, can be summarized in five different principles:

1. Short-term stressors that initiate cases of multisystem illnesses act by stimulating nitric oxide synthase (NOS) activity and consequently produce increased levels of nitric oxide and its oxidant product peroxynitrite.

2. Initiation is converted into a chronic illness through the action of vicious cycle mechanisms, through which chronic elevation of nitric oxide and peroxynitrite is produced and maintained.

3. Symptoms and signs of these illnesses are generated by elevated levels of nitric oxide and/or other important consequences of the proposed mechanism, i.e. elevated levels of peroxynitrite or inflammatory cytokines, oxidative stress and elevated NMDA and vanilloid receptor activity.

4. Because the compounds involved, nitric oxide, superoxide and peroxynitrite have quite limited diffusion distances in biologicaltissues and because most of the mechanisms involved in maintaining the NO/ONOO- cycle act at the level of individual cells, the fundamental mechanisms are local. The consequence of this is that one tissue may be impacted by this underlying biochemistry while an adjacent tissue may be largely unaffected. The tissue distribution may be propagated indefinitely over time by these local vicious cycle mechanisms. This can lead to many differences in symptoms, depending on the tissue distribution variation, from one case to another. This
is such an important principle that I have devoted an entire chapter to it (Chapter 4).

5. Therapy should focus on down-regulating elements of the NO/ONOO- cycle, rather than on just on providing symptomatic relief.

Let me comment on principles 4 and 5. The local nature of the NO/ONOO- cycle means that impact of the cycle on different tissues may be largely independent of each other. Because of this, the symptoms and signs shown by different sufferers of these illnesses are highly variable, depending on which tissues are impacted in which individuals. This variation has been a source of much concern in trying to understand these illnesses but is easily understood as being a consequence of the NO/ONOO- cycle mechanism.

Principle 5 states that therapy should focus on down-regulating NO/ONOO- cycle biochemistry, rather than on symptomatic therapy. The difficulty in doing so can be seen from the complexity of the cycle (Figure 1). Because the cycle has such high level complexity and because scavengers for peroxynitrite, the most central compound in the cycle are inefficient, the approach that may have the most traction is to use multiple agents, particularly well-tolerated nutritional agents, to down-regulate NO/ONOO- cycle biochemistry. This is likely to be the most promising approach to such therapy.

In Chapter 15 of my book, the longest chapter in the book, I discuss 30 different agents or classes of agents that are available today and are predicted to down-regulate NO/ONOO- cycle biochemistry. These are summarized in the table below. I follow with descriptions of treatment protocols independently developed by five different physicians, each of whom use from 14 to 18 agents or classes of agents predicted to down-regulate this biochemistry. While some of these use additional agents, not linked or less obviously linked to NO/ONOO- cvcle biochemistry, I would argue that this pattern is not coincidental. In other words, I argue that:

1. These protocols are largely effective because so many agents in them down-regulate NO/ONOO- cycle biochemistry.
2. The NO/ONOO_ cycle makes useful predictions in terms of therapy and this helps confirm its role as the central cause of these chronic illnesses.

Thirty agents or classes of agents predicted to down-regulate NO/ONOO cycle biochemistry:

Agent or Class of Agents Clinical Trial Data or Clinical Observation/Anecdotal Reports

Vitamin C (ascorbic acid) - Clinical Trial Data
Tocopherols/Tocotrienols - Anecdotal Reports
Selenium - None
Carotenoids - None
Flavonoids - Clinical Trial Data
Reductive stress relieving agents - Clinical Trial Data
Mitochondrial regeneration agents - Clinical Trial Data
L-Carnitine/Acetyl-L-carnitine - Clinical Trial Data
Hydroxocobalamin/B12 - Clinical Trial Data
Folic acid - Clinical Trial Data
Vitamin B6/pyridoxal phosphate - Anecdotal Reports
Riboflavin - None
Other B vitamins - None
Glutathione/glutathione precursors - Clinical Observations
alpha-Lipoic acid - None
Magnesium - Clinical Trial Data
SOD minerals/zinc,manganese, copper - None
NMDA antagonists - Clinical Trial Data
Riluzole - None
Taurine - None
Inosine/uric acid - None
Long chain omega-3 fatty acids - Clinical Trial Data
Agents that lower NF-kappa B activity - Anecdotal Reports
Curcumin - None
Algal supplements - Clinical Trial Data
Hyperbaric oxygen - Clinical Trial Data
Minocycline and Other Tetracyclines - Clinical Observations
Creatine - None
Lowered vanilloid activity - None
Carnosine - None
TRH - Clinical Observations

You will note that there is clinical trial data on the efficacy of 12 of these agents or classes of agents, and there are clinical observations and/or anecdotal evidence of efficacy of six others. Nonetheless, each of these individually, have limited efficacy, suggesting that combinations may be more effective than are individual agents.

Treatment protocols of five different physicians

The comments after some of these agents are mine, not those of the physicians involved: These are listed in no particular order.

Agents from Cheney Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

High dose hydroxocobalamin (B12) injections - nitric oxide scavenger
Whey protein - glutathione precursor
Guaifenesin - vanilloid antagonist?
NMDA blockers
Magnesium - lowers NMDA activity
Taurine - antioxidant and acts to lower excitotoxicity including NMDA activity
GABA agonists - GABA acts as an inhibitory neurotransmitter to lower NMDA activity - these include the drug neurotin (gabapentin)
Histamine blockers - mast cells which release histamine are activated by both nitric oxide and vanilloid stimulation and may therefore be part of the cycle mechanism
Betaine hydrochloride (HCl) - Betaine lowers reductive stress, the hydrochloride form should only be used in those with low stomach acid. Betaine (trimethylglycine) is also listed separately in the protocol description
Flavonoids, including "bioflavonoids," olive leaf extract, organic botanicals, hawthorn extract
Vitamin E (forms not listed)
Coenzyme Q10 - acts both as antioxidant and to stimulate mitochondrial function
A-lipoic acid
Selenium
Omega-3 and -6 fatty acids
Melatonin - as an antioxidant
Pyridoxal phosphate - improves glutamate/GABA ratio
Folic acid - lowers uncoupling of nitric oxide synthases

Agents from Teitelbaum Protocol Predicted to Down-Regulate NO/ONOO Cycle Biochemistry

Daily energy B-complex - B vitamins including high dose B6, riboflavin, thiamine, niacin and also folic acid. These fall into four categories that I have listed earlier in the chapter
Betaine hydrochloride (HCl) - lowers reductive stress, hydrochloride -form should only be taken by those deficient in stomach acid
Magnesium as magnesium glycinate and magnesium malate - lowers NMDA activity - often uses magnesium injections
A-Lipoic acid - important antioxidant helps regenerate reduced glutathione
Vitamin B12 IM injections, 3 mg injections (does not state whether this is hydroxocobalamin) - may act as potent nitric oxide scavenger
Eskimo fish oil - excellent source of long chain omega-3 fatty acids. Lowers iNOS induction, anti-inflammatory
Vitamin C
Grape seed extract (flavonoid)
Vitamin E, natural - does not state whether this includes g-tocopherol or tocotrienols
Physician's protein formula, used as glutathione precursor
Zinc - antioxidant properties and copper/zinc superoxide dysmutase precursor
Acetyl-L-carnitine - important for restoring mitochondrial function
Coenzyme Q10 - both important antioxidant properties and stimulates mitochondrial function

Agents from Nicolson Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Other phosphatidyl polyunsaturated lipids - this and the phosphatidyl choline are predicted to help restore the oxidatively damaged mitochondrial inner membrane
Magnesium - lowers NMDA activity, may aid in energy metabolism
Taurine - antioxidant activity and lowers excitoxicity including NMDA activity
Artichoke extract - as flavonoid source?
Spirulina - blue-green alga is a concentrated antioxidant source
Natural vitamin E - does not tell us whether this includes g-tocopherol or tocotrienols
Calcium ascorbate - vitamin C
a-Lipoic acid - important antioxidant, key role in regeneration of reduced glutathione, but also has role in energy metabolism
Vitamin B6 - balance glutamate and GABA levels, lowers excitotoxicity
Niacin - role in energy metabolism
Riboflavin - important in reduction of oxidized glutathione back to reduced glutathione; also has important role in mitochondrial function
Thiamin - role in energy metabolism
Vitamin B12 - as nitric oxide scavenger?
Folic acid - lowers nitric oxide synthase uncoupling

Agents from Petrovic Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Valine and isoleucine - branched chain amino acids known to be involved in energy metabolism in mitochondria, and may be expected,therefore, to stimulate energy metabolism; modest levels may also lower excitotoxicity
Pyridoxine (B6) - improves balance between glutamate and GABA, lowers excitotoxicity
Vitamin B12 in the form of cyanocobalamin - cyanocobalamin is converted to hydroxocobalamin in the human body but the latter form will be more active as a nitric oxide scavenger, since it does not require such conversion
Riboflavin - helps reduce oxidized glutathione back to reduced glutathione
Carotenoids (alpha-carotene, bixin, zeaxanthin and lutein) - lipid (fat) soluble peroxynitrite scavengers
Flavonoids (flavones, rutin, hesperetin and others)
Ascorbic acid (vitamin C)
Tocotrienols - forms of vitamin E reported to have special roles in lowering effects of excitotoxicity
Thiamine (aneurin) - B vitamin involved in energy metabolism
Magnesium - lowers NMDA activity; may aid energy metabolism
Zinc - precursor of SOD
Betaine hydrochloride (HCl) - lowers reductive stress, hydrochloride form should only be used by those deficient in stomach acid
Essential fatty acids including long chain omega-3 fatty acids
Phosphatidyl serine - reported to lower iNOS induction

Agents from Pall/Ziem Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Nebulized, inhaled reduced glutathione
Nebulized, inhaled hydroxocobalamin (some use sublingual)
Mixed, natural tocopherols including g-tocopherol
Buffered vitamin C
Magnesium as malate
Four different flavonoid sources: Ginkgo biloba extract, cranberry extract, silymarin, and bilberry extract
Selenium as selenium - grown yeast
Coenzyme Q10
Folic acid
Carotenoids including lycopene, lutein and b-carotene
a-Lipoic acid
Zinc (modest dose), manganese (low dose) and copper (low dose)
Vitamin B6 in the form of pyridoxal phosphate
Riboflavin 5'-phosphate (FMN)
Betaine (trimethylglycine)
Dr. Ziem has recently added two additional agents: green tea extract (flanonoids) and acetyl L-carnitine.

Let me add three additional important points:

It is important, with all of these treatments, to avoid up-regulating NO/ONOO- cycle biochemistry. A number of things will tend to produce such up-regulation. These include chemical exposure in MCS patients, excessive exercise in CFS patients, excitotoxin exposure (including MSG and aspartame) in all of these diseases/illnesses, exposure to food allergens in those who have food intolerances and psychological stress in those sensitive to such stress. These treatments are only effective when the agents down-regulating NO/ONOO- cycle biochemistry are taken along with avoidance of stressors predicted to up-regulate such biochemistry.

The second point is that I think that all of these protocols can be improved and I suspect that the physicians who developed them would agree with this. Nevertheless, I would argue that we now know how to effectively treat these diseases/illnesses and that such treatment consistently involves down-regulating the fundamental etiologic cycle that causes them.

The third is that we now have sufficient evidence supporting the NO/ONOO cycle etiology of these diseases/illnesses. This is the only detailed explanation for the many overlaps among these illnesses, their substantial comorbidity with each other and the extraordinary variation in symptoms and signs from one case to another. In other words these are true diseases, with a defined morbid process and etiology, albeit ones with unusual variation from case to case due to the local nature of the underlying biochemistry. This is a major new paradigm of human disease, and there are other diseases/illnesses that are candidates for inclusion under this paradigm."

Martin L. (Marty) Pall
Professor of Biochemistry and Basic Medical Sciences
Washington State University
phone 509-335-1246
fax 509-335-9688

2006-11-20T15:30:00.000-08:00

Page Under Construction
Please Visit Us Again

Return To
informedbattle.blogspot.com

Treatment Options

2006-11-20T14:09:00.000-08:00

Treatment protocols of five different physicians
Abstract from Dr. Martin Pall's writings
For full article see: The NO/ONOO- Cycle Mechanism : Context & Indications for Treatment

Cheney Protocol

Agents from Cheney Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

High dose hydroxocobalamin (B12) injections - nitric oxide scavenger
Whey protein - glutathione precursor
Guaifenesin - vanilloid antagonist?
NMDA blockers
Magnesium - lowers NMDA activity
Taurine - antioxidant and acts to lower excitotoxicity including NMDA activity
GABA agonists - GABA acts as an inhibitory neurotransmitter to lower NMDA activity - these include the drug neurotin (gabapentin)
Histamine blockers - mast cells which release histamine are activated by both nitric oxide and vanilloid stimulation and may therefore be part of the cycle mechanism
Betaine hydrochloride (HCl) - Betaine lowers reductive stress, the hydrochloride form should only be used in those with low stomach acid. Betaine (trimethylglycine) is also listed separately in the protocol description
Flavonoids, including "bioflavonoids," olive leaf extract, organic botanicals, hawthorn extract
Vitamin E (forms not listed)
Coenzyme Q10 - acts both as antioxidant and to stimulate mitochondrial function
A-lipoic acid
Selenium
Omega-3 and -6 fatty acids
Melatonin - as an antioxidant
Pyridoxal phosphate - improves glutamate/GABA ratio
Folic acid - lowers uncoupling of nitric oxide synthases

Teitelbaum Protocol
Agents from Teitelbaum Protocol Predicted to Down-Regulate NO/ONOO Cycle Biochemistry

Daily energy B-complex - B vitamins including high dose B6, riboflavin, thiamine, niacin and also folic acid. These fall into four categories that I have listed earlier in the chapter
Betaine hydrochloride (HCl) - lowers reductive stress, hydrochloride -form should only be taken by those deficient in stomach acid
Magnesium as magnesium glycinate and magnesium malate - lowers NMDA activity - often uses magnesium injections
A-Lipoic acid - important antioxidant helps regenerate reduced glutathione
Vitamin B12 IM injections, 3 mg injections (does not state whether this is hydroxocobalamin) - may act as potent nitric oxide scavenger
Eskimo fish oil - excellent source of long chain omega-3 fatty acids. Lowers iNOS induction, anti-inflammatory
Vitamin C
Grape seed extract (flavonoid)
Vitamin E, natural - does not state whether this includes g-tocopherol or tocotrienols
Physician's protein formula, used as glutathione precursor
Zinc - antioxidant properties and copper/zinc superoxide dysmutase precursor
Acetyl-L-carnitine - important for restoring mitochondrial function
Coenzyme Q10 - both important antioxidant properties and stimulates mitochondrial function

Nicolson Protocol
Agents from Nicolson Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Other phosphatidyl polyunsaturated lipids - this and the phosphatidyl choline are predicted to help restore the oxidatively damaged mitochondrial inner membrane
Magnesium - lowers NMDA activity, may aid in energy metabolism
Taurine - antioxidant activity and lowers excitoxicity including NMDA activity
Artichoke extract - as flavonoid source?
Spirulina - blue-green alga is a concentrated antioxidant source
Natural vitamin E - does not tell us whether this includes g-tocopherol or tocotrienols
Calcium ascorbate - vitamin C
a-Lipoic acid - important antioxidant, key role in regeneration of reduced glutathione, but also has role in energy metabolism
Vitamin B6 - balance glutamate and GABA levels, lowers excitotoxicity
Niacin - role in energy metabolism
Riboflavin - important in reduction of oxidized glutathione back to reduced glutathione; also has important role in mitochondrial function
Thiamin - role in energy metabolism
Vitamin B12 - as nitric oxide scavenger?
Folic acid - lowers nitric oxide synthase uncoupling

Petrovic Protocol
Agents from Petrovic Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Valine and isoleucine - branched chain amino acids known to be involved in energy metabolism in mitochondria, and may be expected,therefore, to stimulate energy metabolism; modest levels may also lower excitotoxicity
Pyridoxine (B6) - improves balance between glutamate and GABA, lowers excitotoxicity
Vitamin B12 in the form of cyanocobalamin - cyanocobalamin is converted to hydroxocobalamin in the human body but the latter form will be more active as a nitric oxide scavenger, since it does not require such conversion
Riboflavin - helps reduce oxidized glutathione back to reduced glutathione
Carotenoids (alpha-carotene, bixin, zeaxanthin and lutein) - lipid (fat) soluble peroxynitrite scavengers
Flavonoids (flavones, rutin, hesperetin and others)
Ascorbic acid (vitamin C)
Tocotrienols - forms of vitamin E reported to have special roles in lowering effects of excitotoxicity
Thiamine (aneurin) - B vitamin involved in energy metabolism
Magnesium - lowers NMDA activity; may aid energy metabolism
Zinc - precursor of SOD
Betaine hydrochloride (HCl) - lowers reductive stress, hydrochloride form should only be used by those deficient in stomach acid
Essential fatty acids including long chain omega-3 fatty acids
Phosphatidyl serine - reported to lower iNOS induction

Pall/Ziem Protocol
Agents from Pall/Ziem Protocol Predicted to Down-Regulate NO/ONOO- Cycle Biochemistry

Nebulized, inhaled reduced glutathione
Nebulized, inhaled hydroxocobalamin (some use sublingual)
Mixed, natural tocopherols including g-tocopherol
Buffered vitamin C
Magnesium as malate
Four different flavonoid sources: Ginkgo biloba extract, cranberry extract, silymarin, and bilberry extract
Selenium as selenium - grown yeast
Coenzyme Q10
Folic acid
Carotenoids including lycopene, lutein and b-carotene
a-Lipoic acid
Zinc (modest dose), manganese (low dose) and copper (low dose)
Vitamin B6 in the form of pyridoxal phosphate
Riboflavin 5'-phosphate (FMN)
Betaine (trimethylglycine)
Dr. Ziem has recently added two additional agents: green tea extract (flanonoids) and acetyl L-carnitine.

For Specifics of the
Pall/Ziem
Neural Protocol
Neural Sensitization: the Medical Key to Treatment
Using the Neural Protocol
Neural Protocol Summary
source:rhema